These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 21996196)

  • 1. Lymphocyte counts in kidney allograft recipients are associated with IMPDH2 3757T>C gene polymorphism.
    Pazik J; Ołdak M; Podgórska M; Lewandowski Z; Sitarek E; Płoski R; Szmidt J; Chmura A; Durlik M; Malejczyk J
    Transplant Proc; 2011 Oct; 43(8):2943-5. PubMed ID: 21996196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An inosine 5'-monophosphate dehydrogenase 2 single-nucleotide polymorphism impairs the effect of mycophenolic acid.
    Winnicki W; Weigel G; Sunder-Plassmann G; Bajari T; Winter B; Herkner H; Sengoelge G
    Pharmacogenomics J; 2010 Feb; 10(1):70-6. PubMed ID: 19770842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interpatient variability in IMPDH activity in MMF-treated renal transplant patients is correlated with IMPDH type II 3757T > C polymorphism.
    Sombogaard F; van Schaik RH; Mathot RA; Budde K; van der Werf M; Vulto AG; Weimar W; Glander P; Essioux L; van Gelder T
    Pharmacogenet Genomics; 2009 Aug; 19(8):626-34. PubMed ID: 19617864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of IMPDH1 and IMPDH2 after transplantation and initiation of immunosuppression.
    Bremer S; Mandla R; Vethe NT; Rasmussen I; Rootwelt H; Line PD; Midtvedt K; Bergan S
    Transplantation; 2008 Jan; 85(1):55-61. PubMed ID: 18192912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IMPDH1 gene polymorphisms and association with acute rejection in renal transplant patients.
    Wang J; Yang JW; Zeevi A; Webber SA; Girnita DM; Selby R; Fu J; Shah T; Pravica V; Hutchinson IV; Burckart GJ
    Clin Pharmacol Ther; 2008 May; 83(5):711-7. PubMed ID: 17851563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inosine monophosphate dehydrogenase polymorphisms and renal allograft outcome.
    Shah S; Harwood SM; Döhler B; Opelz G; Yaqoob MM
    Transplantation; 2012 Sep; 94(5):486-91. PubMed ID: 22960765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inosine monophosphate dehydrogenase type 2 polymorphism IMPDH2 3757T>C (rs11706052) and 12-month evolution of the graft function in renal transplant recipients on mycophenolate-based immunosuppression.
    Penezić L; Nađ-Škegro S; Hadžavdić A; Ganoci L; Kaštelan Ž; Trkulja V; Božina N
    Pharmacogenomics J; 2024 May; 24(3):15. PubMed ID: 38769303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel variant L263F in human inosine 5'-monophosphate dehydrogenase 2 is associated with diminished enzyme activity.
    Wang J; Zeevi A; Webber S; Girnita DM; Addonizio L; Selby R; Hutchinson IV; Burckart GJ
    Pharmacogenet Genomics; 2007 Apr; 17(4):283-90. PubMed ID: 17496727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in IMPDH2, UGT2B7, and CES2 genes influence the risk of graft rejection in kidney transplant recipients taking mycophenolate mofetil.
    Cilião HL; Camargo-Godoy RBO; Souza MF; Zanuto A; Delfino VDA; Cólus IMS
    Mutat Res Genet Toxicol Environ Mutagen; 2018 Dec; 836(Pt B):97-102. PubMed ID: 30442353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of UDP-glucuronosyltransferase 1A9 (UGT1A9) gene polymorphism with kidney allograft function.
    Pazik J; Ołdak M; Dąbrowski M; Lewandowski Z; Sitarek E; Podgórska M; Ważna E; Płoski R; Szmidt J; Chmura A; Durlik M; Malejczyk J
    Ann Transplant; 2011; 16(4):69-73. PubMed ID: 22210424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic interactions between the donor and the recipient for susceptibility to acute rejection in kidney transplantation: polymorphisms of CCR5.
    Cha RH; Yang SH; Kim HS; Kim SM; Park MH; Ha J; Kim YS
    Nephrol Dial Transplant; 2009 Sep; 24(9):2919-25. PubMed ID: 19561149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of four DNA polymorphisms with acute rejection after kidney transplantation.
    Grinyó J; Vanrenterghem Y; Nashan B; Vincenti F; Ekberg H; Lindpaintner K; Rashford M; Nasmyth-Miller C; Voulgari A; Spleiss O; Truman M; Essioux L
    Transpl Int; 2008 Sep; 21(9):879-91. PubMed ID: 18444945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IMP dehydrogenase basal activity in MOLT-4 human leukaemia cells is altered by mycophenolic acid and 6-thioguanosine.
    Vethe NT; Bremer S; Bergan S
    Scand J Clin Lab Invest; 2008; 68(4):277-85. PubMed ID: 18609073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of the associations of IMPDH and UGT1A9 polymorphisms with rejection in kidney transplant recipients taking mycophenolic acid.
    Cheng L; Yao P; Weng B; Yang M; Wang Q
    Eur J Clin Pharmacol; 2022 Aug; 78(8):1227-1238. PubMed ID: 35524809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malnutrition Risk in Kidney Recipients Treated With Mycophenolate Mofetil Is Associated With IMPDH1 rs2278294 Polymorphism.
    Pazik J; Lewandowski Z; Nowacka Cieciura E; Ołdak M; Podgórska M; Sadowska A; Dęborska Materkowska D; Durlik M
    Transplant Proc; 2018; 50(6):1794-1797. PubMed ID: 30056902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uridine diphosphate glucuronosyltransferase 2B7 variant p.His268Tyr as a predictor of kidney allograft early acute rejection.
    Pazik J; Ołdak M; Lewandowski Z; Podgórska M; Sitarek E; Płoski R; Gałazka Z; Kwiatkowski A; Malejczyk J; Durlik M
    Transplant Proc; 2013 May; 45(4):1516-9. PubMed ID: 23726609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 8 -251T>A and Interferon gamma +874A>T polymorphism: potential predictors of allograft outcome in renal transplant recipients from north India.
    Singh R; Kesarwani P; Ahirwar DK; Kapoor R; Mittal RD
    Transpl Immunol; 2009 May; 21(1):13-7. PubMed ID: 19189859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Cyclooxygenase-2 (COX-2) gene promoter-1195 and allograft inflammatory factor-1 (AIF-1) polymorphisms on allograft outcome in Hispanic kidney transplant recipients.
    Vu D; Tellez-Corrales E; Shah T; Hutchinson I; Min DI
    Hum Immunol; 2013 Oct; 74(10):1386-91. PubMed ID: 23777936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics of the mycophenolic acid targets inosine monophosphate dehydrogenases IMPDH1 and IMPDH2: gene sequence variation and functional genomics.
    Wu TY; Peng Y; Pelleymounter LL; Moon I; Eckloff BW; Wieben ED; Yee VC; Weinshilboum RM
    Br J Pharmacol; 2010 Dec; 161(7):1584-98. PubMed ID: 20718729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of IgG subclass levels for infectious complications in renal transplant recipients.
    Wieneke H; Otte B; Lang D; Heidenreich S
    Clin Nephrol; 1996 Jan; 45(1):22-8. PubMed ID: 8616953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.